127 related articles for article (PubMed ID: 12762262)
1. [Cerivastatin and the PRINCESS study: reflexions after 1 year].
Manfredi C; Macrì R; Bartoli M
Ital Heart J Suppl; 2003 Feb; 4(2):125-7. PubMed ID: 12762262
[No Abstract] [Full Text] [Related]
2. [We, the Italian physicians, and statins].
Bobbio M
Ital Heart J Suppl; 2001 Nov; 2(11):1149-54. PubMed ID: 11775405
[TBL] [Abstract][Full Text] [Related]
3. [After recall of cerivastatin. How safe are statins in reality? (interview by Dr. Dirk Einecke)].
Schwandt P
MMW Fortschr Med; 2001 Aug; 143(33-34):12. PubMed ID: 11561452
[No Abstract] [Full Text] [Related]
4. The withdrawal of Baycol (cerivastatin).
Griffin JP
Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168
[No Abstract] [Full Text] [Related]
5. Substituting for cerivastatin (Baycol).
Med Lett Drugs Ther; 2001 Sep; 43(1113):79-80. PubMed ID: 11581579
[No Abstract] [Full Text] [Related]
6. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
[TBL] [Abstract][Full Text] [Related]
7. [Statines for all or individualized lipid lowering therapy?].
Parhofer K
MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
[No Abstract] [Full Text] [Related]
8. Acute effect of cerivastatin on cardiac regional ischemia in a rat model mimicking off-pump coronary surgery.
Nakamura K; Al-Ruzzeh S; Ilsley C; Yacoub MH; Amrani M
J Card Surg; 2005; 20(6):507-11; discussion 512. PubMed ID: 16309399
[TBL] [Abstract][Full Text] [Related]
9. Bayer is forced to release documents over withdrawal of cerivastatin.
Marwick C
BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623898
[No Abstract] [Full Text] [Related]
10. [Surrogate end points as a clinical and public health problem. The cerivastatin case].
Gérvas J; Pérez Fernández M
Med Clin (Barc); 2002 Sep; 119(7):254-9. PubMed ID: 12236985
[No Abstract] [Full Text] [Related]
11. [Treatment of hyperlipidemia in the elderly].
Parhofer K
MMW Fortschr Med; 2008 Nov; 150(47):31-3. PubMed ID: 19189453
[No Abstract] [Full Text] [Related]
12. Baycol: take-home messages about medications.
Harv Heart Lett; 2001 Oct; 12(2):2-3. PubMed ID: 11684487
[No Abstract] [Full Text] [Related]
13. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
Motz W
MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
[No Abstract] [Full Text] [Related]
14. Rhabdomyolysis and cerivastatin: was it a problem of dose?
Kalaria D; Wassenaar W
CMAJ; 2002 Oct; 167(7):737. PubMed ID: 12389822
[No Abstract] [Full Text] [Related]
15. [Prognostic implictions of the lack of a lipid-lowering strategy].
Baessler A; Fischer M; Hubauer U; Stark K; Hengstenberg W; Wiedmann S; Neureuther K; Holmer S; Mayer B; Schunkert H; Hengstenberg C
MMW Fortschr Med; 2006 Nov; 148(44):38. PubMed ID: 17619439
[No Abstract] [Full Text] [Related]
16. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
17. Learning from the cerivastatin experience.
Farmer JA
Lancet; 2001 Oct; 358(9291):1383-5. PubMed ID: 11705478
[No Abstract] [Full Text] [Related]
18. Issues that led to the withdrawal of cerivastatin.
Black DM
Curr Atheroscler Rep; 2003 Jan; 5(1):10. PubMed ID: 12562534
[No Abstract] [Full Text] [Related]
19. Was caution the best advice?
Parchman ML
J Fam Pract; 2007 Feb; 56(2):112-3; author reply 113. PubMed ID: 17611993
[No Abstract] [Full Text] [Related]
20. Re: Low LDL cholesterol, statins, and brain hemorrhage: should we worry?
Vos E; de Groot P
Neurology; 2007 Oct; 69(14):1469; author reply 1470. PubMed ID: 17909161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
